Rasha F El-Demerdash1, Lamiaa N Hammad1, Mohamed M Kamal2, Hala O El Mesallamy2. 1. Pharmacology & Toxicology Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt, 44971. 2. Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt, 11566.
Abstract
AIM: In this study, we investigated the differences between mesenchymal stem cells (MSCs), isolated from umbilical cord blood (UCB-MSCs) and Wharton's jelly (WJ-MSCs) as sources of diabetes mellitus cell therapy. METHODS: After isolation, both cell types were induced to differentiate into insulin producing cells, then the differentiated cells were assessed genetically and functionally. UCB-MSCs and WJ-MSCs were transplanted in the tail veins of streptozotocin-induced diabetic rats. Blood glucose levels were monitored post-transplantation. RESULTS & CONCLUSION: Wharton's jelly was more homogeneous, can better differentiate into insulin producing cells in vitro and better control hyperglycemia in diabetic rats in vivo, as compared with UCB. These results indicate that WJ-MSCs represent a potential source of cells in the field of diabetes mellitus cell therapy.
AIM: In this study, we investigated the differences between mesenchymal stem cells (MSCs), isolated from umbilical cord blood (UCB-MSCs) and Wharton's jelly (WJ-MSCs) as sources of diabetes mellitus cell therapy. METHODS: After isolation, both cell types were induced to differentiate into insulin producing cells, then the differentiated cells were assessed genetically and functionally. UCB-MSCs and WJ-MSCs were transplanted in the tail veins of streptozotocin-induced diabeticrats. Blood glucose levels were monitored post-transplantation. RESULTS & CONCLUSION: Wharton's jelly was more homogeneous, can better differentiate into insulin producing cells in vitro and better control hyperglycemia in diabeticrats in vivo, as compared with UCB. These results indicate that WJ-MSCs represent a potential source of cells in the field of diabetes mellitus cell therapy.
Authors: So Yeon Jung; Young Eun Kim; Won Soon Park; So Yoon Ahn; Dong Kyung Sung; Se In Sung; Kyeung Min Joo; Seong Gi Kim; Yun Sil Chang Journal: Int J Mol Sci Date: 2022-04-18 Impact factor: 6.208
Authors: Jian Wan; Yan Huang; Pengcheng Zhou; Yibing Guo; Cen Wu; Shajun Zhu; Yao Wang; Lei Wang; Yuhua Lu; Zhiwei Wang Journal: Biomed Res Int Date: 2017-04-05 Impact factor: 3.411
Authors: Dina H Kassem; Mohamed M Kamal; Abd El-Latif G El-Kholy; Hala O El-Mesallamy Journal: Stem Cell Res Ther Date: 2016-08-11 Impact factor: 6.832